ConductScience.org, home

Paper32044401

Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate.

Wen WH and 12 others. J Hepatol, 2020. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate. Papers, record 32044401. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32044401

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate.
PubMed
Journal
J Hepatol
PubMed
Year
2020
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2026-05-18
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wen WHWan-Hsin
2Chen HLHuey-Ling
3Shih TTTiffany Ting-Fang
4Wu JFJia-Feng
5Ni YHYen-Hsuan
6Lee CNChien-Nan
7Zhao LLLu-Lu
8Lai MWMing-Wei
9Mu SCShu-Chi
10Tung YCYi-Ching
11Hsu HYHong-Yuan
12Chang MHMei-Hwei
13Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)(‡)Group

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Bone DevelopmentMajor topic
Hepatitis B virusMajor topic
Hepatitis B, ChronicMajor topic
Infectious Disease Transmission, VerticalMajor topic
Pregnancy Complications, InfectiousMajor topic
TenofovirMajor topic
Adult
Child
Child, Preschool
DNA, Viral
Female
Follow-Up Studies
Glomerular Filtration Rate
Humans
Kidney
Male
Pregnancy
Prospective Studies
Young Adult

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01312012The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug TestDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42755564In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42755564PubMed
42328619Chinese clinical practice guidelines for the prevention and treatment of mother-to-child transmission of hepatitis B virus (version 2024).Infect Dis Immun2025https://conductscience.org/library/papers/42328619PubMed
40887644
Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study.
BMC Pregnancy Childbirth2025https://conductscience.org/library/papers/40887644PubMed
40828798Is health, growth and development impaired in children who are Hepatitis B-exposed but uninfected?PLOS Glob Public Health2025https://conductscience.org/library/papers/40828798PubMed
40790753Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D.Virol J2025https://conductscience.org/library/papers/40790753PubMed
40689368Indian National Association for the Study of the Liver Position Statements on Prevention, Diagnosis, and Management of Hepatitis B Virus Infection in India.J Clin Exp Hepatol2025https://conductscience.org/library/papers/40689368PubMed
39544248Chinese Clinical Practice Guidelines for the Prevention and Treatment of Mother-to-child Transmission of Hepatitis B Virus (Version 2024).J Clin Transl Hepatol2024https://conductscience.org/library/papers/39544248PubMed
39528419In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South Africa.J Int AIDS Soc2024https://conductscience.org/library/papers/39528419PubMed
39267564[Chinese practice guidelines for the prevention and treatment of mother-to-child transmission of hepatitis B virus (version 2024)].Zhonghua Gan Zang Bing Za Zhi2024https://conductscience.org/library/papers/39267564PubMed
38805690Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis.Clin Infect Dis2024https://conductscience.org/library/papers/38805690PubMed
37554925Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus.JHEP Rep2023https://conductscience.org/library/papers/37554925PubMed
36304493Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022).J Clin Transl Hepatol2022https://conductscience.org/library/papers/36304493PubMed
35113359Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.Hepatol Int2022https://conductscience.org/library/papers/35113359PubMed
35045168Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus.J Antimicrob Chemother2022https://conductscience.org/library/papers/35045168PubMed
34073357Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B.J Clin Med2021https://conductscience.org/library/papers/34073357PubMed
33979956[Management algorithm for prevention of mother-to-child transmission of hepatitis B virus (2021)].Zhonghua Gan Zang Bing Za Zhi2021https://conductscience.org/library/papers/33979956PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
TENOFOVIRCHEMBL3989702Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3989702

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32044401

GET https://conductscience.org/api/papers/v1/32044401/authors